Loading
OL
Opthea Limited Stock: price and insider trades · Australia
Opthea Limited: what insiders have been doing
Opthea Limited is a listed company based in Australia. Its insiders report their share dealings to ASX. Over the twelve months to 18 October 2026, 4 filings were filed, from 2 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
With 4 filings in twelve months, the company is more active than the median of 3 filings across the 2,222 companies we follow on the same exchange.
Insider buying of Opthea Limited has been absent for the past year.
Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Key facts
Headquarters: Australia
Source: Wikidata (CC0).
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended June 2025 · cache
A$0.01
Analyst consensus
1 analystsA$0.10Target A$0.10(+669%)A$0.10
Income statement
RevenueA$25k
Gross profit-A$58.4k-234% margin
EBITDA-A$123.2M-492760% margin
Net income-A$162.8M-651164.0% margin
Valuation
P/Book0.5x
Beta1.53
Balance sheet & cash
Market capA$17.8M
Free Cash Flow-A$158.7M
Profitability & ownership
ROA-50.4%
% insiders25.9%
% institutions8.4%
Last declaration on 22 June 2026
Declarations4 total
ShareASXISIN AU000000OPT2ASX:2924-03101650-3A695577
ShareASXISIN AU000000OPT2ASX:2924-03098934-3A695048
ShareASXISIN AU000000OPT2ASX:2924-03098513-3A694967
4 of 4 declarations
About Opthea Limited
Opthea Limited is a company listed on the XASX, focused on developing treatments for eye diseases. It emphasizes innovation in the field of visual health.
